Reviewed By
Overview
SCIENTIFIC SCORE
Questionable
Based on 17 Researches
5.9
USERS' SCORE
Medium or Average
Based on 21 Reviews
6.7
Supplement Facts
Serving Size: 2 Softgels
Amount Per Serving
%DV
Calories
20
Total Fat
2 g
3%**
Saturated Fat
0.5 g
3%**
Polyunsaturated Fat
1 g
†
Monounsaturated Fat
0.5 g
†
Fish Oil Concentrate
2 g (2,000 mg)
†
Eicosapentaenoic Acid (EPA)
360 mg
†
Docosahexaenoic Acid (DHA)
240 mg
†
Top Medical Research Studies
We examined whether taking omega-3 fatty acids could enhance the effects of dual antiplatelet therapy for patients dealing with stable angina after heart procedures. Our study involved 40 patients who were split into two groups: one received omega-3 alongside standard medication, while the other did not.
After testing platelet activity over time, we found no significant differences between the two groups. This suggests that omega-3 fish oil does not provide additional benefits for managing chest pain in these patients.
After testing platelet activity over time, we found no significant differences between the two groups. This suggests that omega-3 fish oil does not provide additional benefits for managing chest pain in these patients.
Read More
8
We explored the effects of low-dose fish oil concentrate on patients experiencing angina due to coronary artery disease. In a study with 39 patients, one group received fish oil while the other was given a placebo.
Remarkably, we observed that the fish oil group experienced a 41% reduction in anginal attacks and a significant decrease in medication use over the treatment period. They also enjoyed longer exercise tolerance times and lower serum triglycerides.
Conversely, the placebo group showed no significant changes. Our findings suggest that low-dose fish oil may indeed benefit those struggling with chest pain.
Remarkably, we observed that the fish oil group experienced a 41% reduction in anginal attacks and a significant decrease in medication use over the treatment period. They also enjoyed longer exercise tolerance times and lower serum triglycerides.
Conversely, the placebo group showed no significant changes. Our findings suggest that low-dose fish oil may indeed benefit those struggling with chest pain.
Read More
8
We conducted a trial involving 23 geriatric patients to see if low-dose fish oil could help with angina pectoris.
Using a single-blind, placebo-controlled, crossover design, we discovered that fish oil significantly reduced the number of anginal attacks and the need for sublingual isosorbide dinitrate tablets.
Additionally, there seemed to be a lingering effect of fish oil even after switching to the placebo, suggesting potential long-term benefits.
Using a single-blind, placebo-controlled, crossover design, we discovered that fish oil significantly reduced the number of anginal attacks and the need for sublingual isosorbide dinitrate tablets.
Additionally, there seemed to be a lingering effect of fish oil even after switching to the placebo, suggesting potential long-term benefits.
Read More
Most Useful Reviews
9
Not effective for chest pain
6 people found this helpful
Omega-3s are crucial for health, known since the 1930s. However, I didn’t find any specific effect on my chest pain from this product. I experienced fishy burps, and while studies show benefits, my personal experience wasn’t satisfactory.
Read More
9
Reduces chest pain
3 people found this helpful
This was prescribed for headaches. After three weeks of taking it, my chest pain decreased significantly. I am very pleased with the results and continue to take it as advised by my doctor.
Read More
9
Eliminates chest pain
2 people found this helpful
I began taking Omega-3 on my rheumatologist’s advice due to knee pain. After a month, along with Vitamin D3, my chest pain has vanished and I feel fantastic.
Read More
Medical Researches
SCIENTIFIC SCORE
Questionable
Based on 17 Researches
5.9
- All Researches
8
We investigated whether adding eicosapentaenoic acid (EPA), an omega-3 fatty acid, to statin therapy could help reduce chest pain linked to coronary heart disease. In this randomized controlled trial involving 193 patients, those taking both EPA and pitavastatin experienced a significant reduction in coronary plaque volume compared to those on statins alone.
While the combination therapy particularly benefited patients with stable angina, it did not reduce major cardiovascular events or side effects. This suggests that while EPA may enhance plaque stability, it does not necessarily lower chest pain symptoms in all cases.
While the combination therapy particularly benefited patients with stable angina, it did not reduce major cardiovascular events or side effects. This suggests that while EPA may enhance plaque stability, it does not necessarily lower chest pain symptoms in all cases.
Read More
8
Fish oil reduces cardiac events
We examined the effects of fish oil on chest pain in a randomized trial involving 360 patients experiencing suspected acute myocardial infarction.
After one year, we found that those taking fish oil had significantly fewer cardiac events and nonfatal infarctions compared to the placebo group.
Interestingly, while fish oil appeared to lower cardiac death rates, mustard oil showed no similar benefit.
Overall, this suggests that fish oil may offer protective effects, though more extensive research is needed for confirmation.
After one year, we found that those taking fish oil had significantly fewer cardiac events and nonfatal infarctions compared to the placebo group.
Interestingly, while fish oil appeared to lower cardiac death rates, mustard oil showed no similar benefit.
Overall, this suggests that fish oil may offer protective effects, though more extensive research is needed for confirmation.
Read More
8
We explored the effects of low-dose fish oil concentrate on patients experiencing angina due to coronary artery disease. In a study with 39 patients, one group received fish oil while the other was given a placebo.
Remarkably, we observed that the fish oil group experienced a 41% reduction in anginal attacks and a significant decrease in medication use over the treatment period. They also enjoyed longer exercise tolerance times and lower serum triglycerides.
Conversely, the placebo group showed no significant changes. Our findings suggest that low-dose fish oil may indeed benefit those struggling with chest pain.
Remarkably, we observed that the fish oil group experienced a 41% reduction in anginal attacks and a significant decrease in medication use over the treatment period. They also enjoyed longer exercise tolerance times and lower serum triglycerides.
Conversely, the placebo group showed no significant changes. Our findings suggest that low-dose fish oil may indeed benefit those struggling with chest pain.
Read More
8
We conducted a trial involving 23 geriatric patients to see if low-dose fish oil could help with angina pectoris.
Using a single-blind, placebo-controlled, crossover design, we discovered that fish oil significantly reduced the number of anginal attacks and the need for sublingual isosorbide dinitrate tablets.
Additionally, there seemed to be a lingering effect of fish oil even after switching to the placebo, suggesting potential long-term benefits.
Using a single-blind, placebo-controlled, crossover design, we discovered that fish oil significantly reduced the number of anginal attacks and the need for sublingual isosorbide dinitrate tablets.
Additionally, there seemed to be a lingering effect of fish oil even after switching to the placebo, suggesting potential long-term benefits.
Read More
8
We examined the long-term effects of a fish lipid concentrate high in eicosapentaenoic acid in 107 subjects, some with heart conditions and others without. Over two years, we noticed marked reductions in triglycerides, a mild decrease in total cholesterol, and an increase in HDL cholesterol.
Notably, we found a significant decrease in the use of GTN tablets, correlating with fewer angina attacks. This suggests that omega-3 may help enhance heart health by reducing symptoms and improving lipid profiles, although bleeding times also increased.
Notably, we found a significant decrease in the use of GTN tablets, correlating with fewer angina attacks. This suggests that omega-3 may help enhance heart health by reducing symptoms and improving lipid profiles, although bleeding times also increased.
Read More
User Reviews
USERS' SCORE
Medium or Average
Based on 21 Reviews
6.7
- All Reviews
- Positive Reviews
- Negative Reviews
9
Not effective for chest pain
6 people found this helpful
Omega-3s are crucial for health, known since the 1930s. However, I didn’t find any specific effect on my chest pain from this product. I experienced fishy burps, and while studies show benefits, my personal experience wasn’t satisfactory.
Read More
9
Reduces chest pain
3 people found this helpful
This was prescribed for headaches. After three weeks of taking it, my chest pain decreased significantly. I am very pleased with the results and continue to take it as advised by my doctor.
Read More
9
Eliminates chest pain
2 people found this helpful
I began taking Omega-3 on my rheumatologist’s advice due to knee pain. After a month, along with Vitamin D3, my chest pain has vanished and I feel fantastic.
Read More
9
Less chest pain
2 people found this helpful
I was prescribed this by a neurologist for headaches. After two weeks of taking two capsules daily, my pain has subsided considerably. Highly recommend it.
Read More
9
Reports chest pain improvement
1 people found this helpful
I bought Omega-3 for my elderly father with coronary heart disease, who approached it sceptically. He reported improved chest pain within a week, for which I am exceedingly grateful.
Read More
Frequently Asked Questions
9
Reports chest pain improvement
1 people found this helpful
I bought Omega-3 for my elderly father with coronary heart disease, who approached it sceptically. He reported improved chest pain within a week, for which I am exceedingly grateful.
9
Reduces chest pain
3 people found this helpful
This was prescribed for headaches. After three weeks of taking it, my chest pain decreased significantly. I am very pleased with the results and continue to take it as advised by my doctor.
9
Less chest pain
2 people found this helpful
I was prescribed this by a neurologist for headaches. After two weeks of taking two capsules daily, my pain has subsided considerably. Highly recommend it.
9
Not effective for chest pain
6 people found this helpful
Omega-3s are crucial for health, known since the 1930s. However, I didn’t find any specific effect on my chest pain from this product. I experienced fishy burps, and while studies show benefits, my personal experience wasn’t satisfactory.
7.5
Helps with chest pain
4 people found this helpful
This Omega-3 has significantly improved my joint pain and anxiety levels, along with providing cardiovascular support. I truly appreciate this product and the relief it provides!
9
Chest pain relief
1 people found this helpful
This Omega-3 has been excellent for my advanced post-traumatic arthritis, effectively eliminating my chest pain and improving mobility.
0
Severe chest pain
3 people found this helpful
Initially, I took one capsule twice a day, but on the fifth day, I experienced a fishy belch followed by abdominal discomfort and severe chest pain. I stopped after two attempts due to the intense pain it caused.
9
Eliminates chest pain
2 people found this helpful
I began taking Omega-3 on my rheumatologist’s advice due to knee pain. After a month, along with Vitamin D3, my chest pain has vanished and I feel fantastic.
9
Chest pain relief
I ordered this twice as it helped greatly with my heart pains related to hypertension, especially alongside coenzyme Q10. I will continue taking it.
0
Stopped chest pain
I began taking this supplement and experienced significant stomach pain, leading me to stop immediately. It may have been due to my sensitivity to zinc.
5
Chest pain relief tips
4 people found this helpful
I've taken Omega-3 for years. I noticed unpleasant belching and stomach pain at times. If taken during meals, there are no issues. I will continue ordering more as it has potential benefits.
8
We investigated whether adding eicosapentaenoic acid (EPA), an omega-3 fatty acid, to statin therapy could help reduce chest pain linked to coronary heart disease. In this randomized controlled trial involving 193 patients, those taking both EPA and pitavastatin experienced a significant reduction in coronary plaque volume compared to those on statins alone.
While the combination therapy particularly benefited patients with stable angina, it did not reduce major cardiovascular events or side effects. This suggests that while EPA may enhance plaque stability, it does not necessarily lower chest pain symptoms in all cases.
While the combination therapy particularly benefited patients with stable angina, it did not reduce major cardiovascular events or side effects. This suggests that while EPA may enhance plaque stability, it does not necessarily lower chest pain symptoms in all cases.
8
We explored the effects of low-dose fish oil concentrate on patients experiencing angina due to coronary artery disease. In a study with 39 patients, one group received fish oil while the other was given a placebo.
Remarkably, we observed that the fish oil group experienced a 41% reduction in anginal attacks and a significant decrease in medication use over the treatment period. They also enjoyed longer exercise tolerance times and lower serum triglycerides.
Conversely, the placebo group showed no significant changes. Our findings suggest that low-dose fish oil may indeed benefit those struggling with chest pain.
Remarkably, we observed that the fish oil group experienced a 41% reduction in anginal attacks and a significant decrease in medication use over the treatment period. They also enjoyed longer exercise tolerance times and lower serum triglycerides.
Conversely, the placebo group showed no significant changes. Our findings suggest that low-dose fish oil may indeed benefit those struggling with chest pain.
We examined whether taking omega-3 fatty acids could enhance the effects of dual antiplatelet therapy for patients dealing with stable angina after heart procedures. Our study involved 40 patients who were split into two groups: one received omega-3 alongside standard medication, while the other did not.
After testing platelet activity over time, we found no significant differences between the two groups. This suggests that omega-3 fish oil does not provide additional benefits for managing chest pain in these patients.
After testing platelet activity over time, we found no significant differences between the two groups. This suggests that omega-3 fish oil does not provide additional benefits for managing chest pain in these patients.
7
We explored the effects of omega-3 fatty acids in relation to sudden cardiac death and chest pain in patients with coronary heart disease. After assessing data from eight trials involving nearly 21,000 patients, we found that omega-3 supplementation lowered the risk of sudden cardiac death in those with a history of myocardial infarction.
However, in angina patients, it actually increased the risk of sudden cardiac death. These findings indicate that while omega-3 may beneficially affect some patients, it could pose risks for others.
However, in angina patients, it actually increased the risk of sudden cardiac death. These findings indicate that while omega-3 may beneficially affect some patients, it could pose risks for others.
5
We explored the relationship between omega-3 fatty acids and coronary spastic angina (CSA) in patients undergoing testing for chest pain. The study included 406 participants, divided into age-based groups.
In younger patients (≤65 years), those with CSA exhibited higher serum levels of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) than those without.
In contrast, this association was not observed in older patients. Our findings suggest that higher omega-3 levels may play a role in CSA for younger individuals but not for the elderly.
In younger patients (≤65 years), those with CSA exhibited higher serum levels of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) than those without.
In contrast, this association was not observed in older patients. Our findings suggest that higher omega-3 levels may play a role in CSA for younger individuals but not for the elderly.
References
- Irfan A, Haider SH, Nasir A, Larik MO, Naz T. Assessing the Efficacy of Omega-3 Fatty Acids + Statins vs. Statins Only on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of 40,991 Patients. Curr Probl Cardiol. 2024;49:102245. 10.1016/j.cpcardiol.2023.102245
- Tawara K, Akioka H, Sato H, Sato T, Takahashi M, et al. Role of polyunsaturated fatty acids in Japanese patients with coronary spastic angina. J Cardiol. 2023;82:455. 10.1016/j.jjcc.2023.07.001
- Watanabe T, Ando K, Daidoji H, Otaki Y, Sugawara S, et al. A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins. J Cardiol. 2017;70:537. 10.1016/j.jjcc.2017.07.007
- Gajos G, Zalewski J, Mostowik M, Konduracka E, Nessler J, et al. Polyunsaturated omega-3 fatty acids reduce lipoprotein-associated phospholipase A(2) in patients with stable angina. Nutr Metab Cardiovasc Dis. 2014;24:434. 10.1016/j.numecd.2013.09.011
- Mizia-Stec K, Mizia M, Haberka M, Lasota B, Gieszczyk-Strózik K, et al. N-3 polyunsaturated fatty acids do not influence the efficacy of dual antiplatelet therapy in stable angina pectoris patients after percutaneous coronary intervention. Cardiol J. 2013;20:478. 10.5603/CJ.2013.0132
- Zhao YT, Chen Q, Sun YX, Li XB, Zhang P, et al. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Ann Med. 2009;41:301. 10.1080/07853890802698834
- Singh RB, Niaz MA, Sharma JP, Kumar R, Rastogi V, et al. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival--4. Cardiovasc Drugs Ther. 1997;11:485.
- Yamamoto H, Yoshimura H, Noma M, Suzuki S, Kai H, et al. Improvement of coronary vasomotion with eicosapentaenoic acid does not inhibit acetylcholine-induced coronary vasospasm in patients with variant angina. Jpn Circ J. 1995;59:608.
- Salachas A, Papadopoulos C, Sakadamis G, Styliadis J, Voudris V, et al. Effects of a low-dose fish oil concentrate on angina, exercise tolerance time, serum triglycerides, and platelet function. Angiology. 1994;45:1023.
- Aucamp AK, Schoeman HS, Coetzee JH. Pilot trial to determine the efficacy of a low dose of fish oil in the treatment of angina pectoris in the geriatric patient. Prostaglandins Leukot Essent Fatty Acids. 1993;49:687.
- Kalinkina OM, Gratsianskiĭ NA, Perova NV, Metel'skaia VA, Zykova VP, et al. [Newly developed stenocardia: effect of diet with increased amount of polyunsaturated fatty acids of the omega-3 group on blood lipids and apolipoproteins]. Kardiologiia. 1990;30:34.
- Kalinkina OM, Perova NV, Zykova VP, Gratsianskiĭ NA, Mel'kina OE, et al. [The effect of a diet enriched with omega-3 polyunsaturated fatty acids on thrombocyte functional activity and on the blood lipid-apolipoprotein spectrum in newly occurring stenocardia]. Ter Arkh. 1990;62:77.
- Solomon SA, Cartwright I, Pockley G, Greaves M, Preston FE, et al. A placebo-controlled, double-blind study of eicosapentaenoic acid-rich fish oil in patients with stable angina pectoris. Curr Med Res Opin. 1990;12:1.
- Saynor R, Verel D, Gillott T. The long-term effect of dietary supplementation with fish lipid concentrate on serum lipids, bleeding time, platelets and angina. Atherosclerosis. 1984;50:3.
- Zykova VP, Perova NV, Kalinkina OM. [Study of in vitro thromboxane A2 generation by platelets of patients with first-time appearing angina pectoris under the effect of fish diet]. Kardiologiia. 1990;30:24.
- Schmidt EB, Kristensen SD, Dyerberg J. The effect of fish oil on lipids, coagulation and fibrinolysis in patients with angina pectoris. Artery. 1988;15:316.
- Kondo T, Ogawa K, Satake T, Kitazawa M, Taki K, et al. Plasma-free eicosapentaenoic acid/arachidonic acid ratio: a possible new coronary risk factor. Clin Cardiol. 1986;9:413.
